Papers
1
Total Citations
5
H-Index
1
About
Yanping Hu is a leading virologist whose work centers on developing practical, high-impact solutions for pandemic response, with a primary focus on SARS-CoV-2 serology and neutralization assays. Her most significant contribution is the creation of an integrated research-clinical BSL-2 platform for a live SARS-CoV-2 neutralization assay, a breakthrough that enables safe, efficient, and scalable monitoring of neutralizing antibodies against the virus and its variants of concern. By utilizing a highly attenuated SARS-CoV-2 strain (Δ3678_WA1-s), this platform bridges the critical gap between high-level biosafety research and routine clinical diagnostics, making sophisticated antibody testing accessible for broader public health use. Although a relatively recent publication (2023), this work has already garnered 5 citations, underscoring its immediate relevance and adoption by the scientific community. Hu’s research is distinguished by its translational focus—transforming complex virology into reliable, real-world tools. For students and researchers, Yanping Hu exemplifies how innovative assay design can directly fortify global health defenses against emerging viral threats, offering a model for practical, safety-conscious research in infectious disease.
Research Focus
Key Achievements
Top Papers
- 1